Anti-neoplastic drugs have made major advancements in oncology, however they are not without cardiovascular consequences. We present a patient with cutaneous T-cell lymphoma receiving Targretin therapy who presented with accelerated atherosclerosis. His triglyceride level (TG) was greater than 1000 mg/dL, which rapidly improved with discontinuation of Targretin.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734706 | PMC |
| http://dx.doi.org/10.1186/s40959-020-00087-3 | DOI Listing |
Publication Analysis
Top Keywords
case report
4
report rapid
4
rapid progression
4
progression coronary
4
coronary atherosclerosis
4
atherosclerosis patient
4
patient targretin
4
targretin bexarotene
4
bexarotene anti-neoplastic
4
anti-neoplastic drugs
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!